Raymond James & Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $83.6M | Buy |
|
|||||
|
2024
Q2 | $123M | Buy |
|
|||||
|
2024
Q1 | $143M | Buy |
|
|||||
|
2023
Q4 | $22.1M | Sell |
|
|||||
|
2023
Q3 | $30M | Sell |
|
|||||
|
2023
Q2 | $45.4M | Buy |
|
|||||
|
2023
Q1 | $37.6M | Sell |
|
|||||
|
2022
Q4 | $44.6M | Sell |
|
|||||
|
2022
Q3 | $36.4M | Sell |
|
|||||
|
2022
Q2 | $36M | Buy |
|
|||||
|
2022
Q1 | $58.2M | Buy |
|
|||||
|
2021
Q4 | $57.7M | Sell |
|
|||||
|
2021
Q3 | $62.1M | Buy |
|
|||||
|
2021
Q2 | $46.5M | Buy |
|
|||||
|
2021
Q1 | $17.3M | Sell |
|
|||||
|
2020
Q4 | $18.8M | Sell |
|
|||||
|
2020
Q3 | $34.3M | Buy |
|
|||||
|
2020
Q2 | $32.5M | Buy |
|
|||||
|
2020
Q1 | $21M | Buy |
|
|||||
|
2019
Q4 | $13.1M | Buy |
|
|||||
|
2019
Q3 | $7.71M | Buy |
|
|||||
|
2019
Q2 | $5.63M | Sell |
|
|||||
|
2019
Q1 | $5.23M | Buy |
|
|||||
|
2018
Q4 | $4.99M | Buy |
|
|||||
|
2018
Q3 | $4.36M | Buy |
|
|||||
|
2018
Q2 | $2.86M | Buy |
|
|||||
|
2018
Q1 | $2.11M | Sell |
|
|||||
|
2017
Q4 | $2.12M | Sell |
|
|||||
|
2017
Q3 | $3.52M | Sell |
|
|||||
|
2017
Q2 | $5.64M | Buy |
|
|||||
|
2017
Q1 | $5.92M | Sell |
|
|||||
|
2016
Q4 | $8.17M | Buy |
|
|||||
|
2016
Q3 | $7.97M | Buy |
|
|||||
|
2016
Q2 | $4.32M | Buy |
|
|||||
|
2016
Q1 | $3.44M | Sell |
|
|||||
|
2015
Q4 | $4.61M | Sell |
|
|||||
|
2015
Q3 | $5.25M | Sell |
|
|||||
|
2015
Q2 | $5.17M | Buy |
|
|||||
|
2015
Q1 | $3.93M | Sell |
|
|||||
|
2014
Q4 | $3.48M | Sell |
|
|||||
|
2014
Q3 | $2.63M | Sell |
|
|||||
|
2014
Q2 | $2.67M | Sell |
|
|||||
|
2014
Q1 | $3.29M | Sell |
|
|||||
|
2013
Q4 | $3.24M | Sell |
|
|||||
|
2013
Q3 | $2.73M | Sell |
|
|||||
|
2013
Q2 | $3.71M | Buy |
|